Trial intelligence / Profile preview

Preoperative IOP reduction with preservative-free COSOPT-S vs oral acetazolamide + dexamethasone in trabeculectomy for glaucoma

2010-019975-30Phase 4Completed

Sponsor
University Medical Center Mainz
Start
Jun 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dorzolamide + timolol in Glaucoma (2 arms), sponsored by University Medical Center Mainz. Primary endpoint: Mean intraocular pressure reduction at 3 months post-trabeculectomy. Started Jun 2010; status: completed.

02

Drugs

dorzolamide + timolol
03

Conditions

Glaucoma

Beyond the preview

Go deeper on 2010-019975-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-019975-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call